26-Mar-2008 - Drug regulator Health Canada has published its draft guidelines for pharmaceutical firms seeking to gain approval for biosimilars or "subsequent entry biologics."
Link to Article
in-pharmatechnologist.com
|
|
||||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
General Health Care News RSS
|
Health Canada issues draft rules for subsequent entry biologics
by
Alex Hsieh on behalf of Professor Henry Wang
on Thu 27 Mar 2008 11:42 PM EDT | Permanent Link
| Cosmos
No comments found.
|
Search
Links
|
||||